IFO50322 NJG
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50322 | Cell Name | NJG |
---|---|---|---|
Profile | gestational uterine choriocarcinoma | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | |
Identity | available | Tissue for Primary Cancer | uterus |
Case history | gestational uterine choriocarcinoma | Metastasis | |
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | Character | gestational uterine choriocarcinoma | |
Classify | tumor | Established by | Nozawa, S. |
Registered by | Nozawa,S. | Regulation for Distribution | |
Comment | This cell line does not contain a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). | Year | 1991 |
Medium | Ham's F12 medium with 10% fetal bovine serum | Methods for Passages | trypsin-EDTA |
Cell Number on Passage | Race | ||
CO2 Conc. | 5 % | Tissue Sampling | uterus |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:9125195 | Presence of mRNAs encoding the soluble D-factor/LIF receptor in human choriocarcinoma cells and production of the soluble receptor. Tomida M Biochem Biophys Res Commun. 1997 Mar 17;232(2):427-31 |
Pubmed id:3611867 | [Establishment and characteristics of a new human choriocarcinoma cell line and its production of tumor markers]. Nozawa S,Udagawa Y,Sakayori M,Tsukazaki K,Takayama Y,Aoki D,Kubushiro K,Iizuka R,Inaba N Nihon Sanka Fujinka Gakkai Zasshi. 1987 Jun;39(6):889-96 |
Images |
---|
LOT Information
Cell No. | IFO50322 | Cell Name | |
---|---|---|---|
LOT No. | 06132007 | Lot Specification | distribution |
Medium | Ham's F12 medium with 10% fetal bovine serum (FBS lot; GIBCO 484375) | Temperature | 37 C |
Cell Density at Seeding | 2-5 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | 34 hrs | Cell Number in Vial (cells/1ml) | 2.6 x 10^6 |
Viability at cell freezing (%) | 85 | Antibiotics Used | free |
Passage Number | Unknown (11 at cellbank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD, AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:13 D13S317:11 D7S820:10 D16S539:12 VWA:16 TH01:9 AM:X TPOX:8 CSF1PO:13 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - Ham's F12 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50322 | Cell Name | NJG |
---|---|---|---|
LOT No. | 1015 | Lot Specification | distribution |
Medium | Ham's F12, 90% ; FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | trypsin-EDTA | |
Doubling Time | Cell Number in Vial (cells/1ml) | 8 x 10^5 | |
Viability at cell freezing (%) | 80 | Antibiotics Used | free |
Passage Number | Unknown (>7 at IFO) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type B), MD |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |